Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Coexistence of Guillain-Barré syndrome and Behçet's disease.
Sleep-disordered breathing in multiple sclerosis.
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status.
Combining two multiple sclerosis treatments has no clinical benefit, study finds.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients.
State vocational rehabilitation services and employment in multiple sclerosis.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis in US minority populations: Clinical practice insights.
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Linking synaptopathy and gray matter damage in multiple sclerosis.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Th17 cells in central nervous system autoimmunity.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Use of botulinum toxin for genitourinary conditions: What is the evidence?

Pages